duchenne uk
duchenne uk Company Information
Company Number
08030768
Next Accounts
Sep 2025
Shareholders
-
Group Structure
View All
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
+2Registered Address
unit g.24, shepherd's building, charecroft way, london, W14 0EE
Website
www.duchenneuk.orgduchenne uk Estimated Valuation
Pomanda estimates the enterprise value of DUCHENNE UK at £3.7m based on a Turnover of £3.9m and 0.95x industry multiple (adjusted for size and gross margin).
duchenne uk Estimated Valuation
Pomanda estimates the enterprise value of DUCHENNE UK at £5.6m based on an EBITDA of £1.1m and a 4.9x industry multiple (adjusted for size and gross margin).
duchenne uk Estimated Valuation
Pomanda estimates the enterprise value of DUCHENNE UK at £9.4m based on Net Assets of £4.4m and 2.16x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Duchenne Uk Overview
Duchenne Uk is a live company located in london, W14 0EE with a Companies House number of 08030768. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in April 2012, it's largest shareholder is unknown. Duchenne Uk is a established, small sized company, Pomanda has estimated its turnover at £3.9m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Duchenne Uk Health Check
Pomanda's financial health check has awarded Duchenne Uk a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 1 areas for improvement. Company Health Check FAQs
7 Strong
2 Regular
1 Weak
Size
annual sales of £3.9m, make it larger than the average company (£2.6m)
£3.9m - Duchenne Uk
£2.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 34%, show it is growing at a faster rate (9%)
34% - Duchenne Uk
9% - Industry AVG
Production
with a gross margin of 51.9%, this company has a comparable cost of product (51.9%)
51.9% - Duchenne Uk
51.9% - Industry AVG
Profitability
an operating margin of 29.1% make it more profitable than the average company (1.9%)
29.1% - Duchenne Uk
1.9% - Industry AVG
Employees
with 15 employees, this is below the industry average (29)
15 - Duchenne Uk
29 - Industry AVG
Pay Structure
on an average salary of £47k, the company has an equivalent pay structure (£55.2k)
£47k - Duchenne Uk
£55.2k - Industry AVG
Efficiency
resulting in sales per employee of £262.7k, this is more efficient (£103.2k)
£262.7k - Duchenne Uk
£103.2k - Industry AVG
Debtor Days
it gets paid by customers after 33 days, this is earlier than average (43 days)
33 days - Duchenne Uk
43 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Duchenne Uk
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Duchenne Uk
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 99 weeks, this is more cash available to meet short term requirements (56 weeks)
99 weeks - Duchenne Uk
56 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 29.3%, this is a lower level of debt than the average (43.5%)
29.3% - Duchenne Uk
43.5% - Industry AVG
DUCHENNE UK financials
Duchenne Uk's latest turnover from December 2023 is £3.9 million and the company has net assets of £4.4 million. According to their latest financial statements, Duchenne Uk has 15 employees and maintains cash reserves of £2.6 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 3,940,704 | 3,757,736 | 1,619,240 | 1,637,377 | 2,897,766 | 3,979,427 | 3,948,623 | 2,356,582 | 1,199,339 | 964,031 | 975,759 | 482,176 |
| Other Income Or Grants | ||||||||||||
| Cost Of Sales | ||||||||||||
| Gross Profit | ||||||||||||
| Admin Expenses | ||||||||||||
| Operating Profit | -451,988 | |||||||||||
| Interest Payable | ||||||||||||
| Interest Receivable | ||||||||||||
| Pre-Tax Profit | 946,503 | 2,192,167 | -969,829 | -244,516 | -692,757 | -2,199,405 | 1,910,099 | 1,408,682 | 692,035 | 1,604,996 | -355,200 | 452,863 |
| Tax | ||||||||||||
| Profit After Tax | 946,503 | 2,192,167 | -969,829 | -244,516 | -692,757 | -2,199,405 | 1,910,099 | 1,408,682 | 692,035 | 1,604,996 | -355,200 | 452,863 |
| Dividends Paid | ||||||||||||
| Retained Profit | 946,503 | 2,192,167 | -969,829 | -244,516 | -692,757 | -2,199,405 | 1,910,099 | 1,408,682 | 692,035 | 1,604,996 | -355,200 | 452,863 |
| Employee Costs | 704,548 | 541,535 | 348,381 | 185,044 | 192,071 | 161,848 | 142,817 | 46,388 | ||||
| Number Of Employees | 15 | 13 | 10 | 7 | 6 | 5 | 5 | 3 | ||||
| EBITDA* | -450,611 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 2,886 | 3,864 | 2,755 | 2,159 | 645 | 1,153 | ||||||
| Intangible Assets | ||||||||||||
| Investments & Other | 55,784 | 51,436 | 224,345 | 811,453 | 313,450 | 1,089,245 | 1,089,245 | 1,089,245 | 1,089,245 | 541,000 | ||
| Debtors (Due After 1 year) | ||||||||||||
| Total Fixed Assets | 58,670 | 55,300 | 227,100 | 813,612 | 313,450 | 1,089,890 | 1,090,398 | 1,089,245 | 1,089,245 | 541,000 | ||
| Stock & work in progress | 5,661 | 7,650 | ||||||||||
| Trade Debtors | 366,210 | 188,423 | 2,622 | 48,693 | 75,635 | 187,199 | 69,967 | 32,936 | ||||
| Group Debtors | 256,959 | |||||||||||
| Misc Debtors | 106,988 | 666,543 | 46,840 | 643,359 | 201,526 | 348,914 | 1,094,407 | 1,041,282 | 163,360 | 595,150 | ||
| Cash | 2,558,199 | 1,886,523 | 1,257,545 | 4,862,606 | 4,915,354 | 5,740,409 | 3,624,718 | 1,813,555 | 1,077,621 | 603,603 | 847,871 | 414,382 |
| misc current assets | 3,067,532 | 3,079,754 | 3,069,267 | |||||||||
| total current assets | 6,098,929 | 5,821,243 | 4,376,274 | 5,505,965 | 5,373,839 | 6,089,323 | 4,767,818 | 2,930,472 | 1,428,180 | 1,198,753 | 923,499 | 454,968 |
| total assets | 6,157,599 | 5,876,543 | 4,603,374 | 6,319,577 | 5,687,289 | 7,179,213 | 5,858,216 | 4,019,717 | 2,517,425 | 1,739,753 | 923,499 | 454,968 |
| Bank overdraft | ||||||||||||
| Bank loan | ||||||||||||
| Trade Creditors | ||||||||||||
| Group/Directors Accounts | ||||||||||||
| other short term finances | ||||||||||||
| hp & lease commitments | ||||||||||||
| other current liabilities | 1,342,013 | 2,166,165 | 2,786,523 | 2,686,981 | 2,098,335 | 2,132,815 | 144,741 | 216,341 | 122,731 | 37,094 | 825,836 | 2,105 |
| total current liabilities | 1,342,013 | 2,166,165 | 2,786,523 | 2,686,981 | 2,098,335 | 2,132,815 | 144,741 | 216,341 | 122,731 | 37,094 | 825,836 | 2,105 |
| loans | ||||||||||||
| hp & lease commitments | ||||||||||||
| Accruals and Deferred Income | ||||||||||||
| other liabilities | 461,715 | 231,037 | 487,675 | 1,333,591 | 1,543,436 | 1,532,328 | ||||||
| provisions | ||||||||||||
| total long term liabilities | 461,715 | 231,037 | 487,675 | 1,333,591 | 1,543,436 | 1,532,328 | ||||||
| total liabilities | 1,803,728 | 2,397,202 | 3,274,198 | 4,020,572 | 3,641,771 | 3,665,143 | 144,741 | 216,341 | 122,731 | 37,094 | 825,836 | 2,105 |
| net assets | 4,353,871 | 3,479,341 | 1,329,176 | 2,299,005 | 2,045,518 | 3,514,070 | 5,713,475 | 3,803,376 | 2,394,694 | 1,702,659 | 97,663 | 452,863 |
| total shareholders funds | 4,353,871 | 3,479,341 | 1,329,176 | 2,299,005 | 2,045,518 | 3,514,070 | 5,713,475 | 3,803,376 | 2,394,694 | 1,702,659 | 97,663 | 452,863 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Operating Profit | -451,988 | |||||||||||
| Depreciation | 2,781 | 2,261 | 1,377 | 645 | 508 | 507 | ||||||
| Amortisation | ||||||||||||
| Tax | ||||||||||||
| Stock | -5,661 | -1,989 | 7,650 | |||||||||
| Debtors | -381,768 | 805,504 | -593,897 | 294,445 | 109,571 | -794,186 | 26,183 | 766,358 | -244,591 | 525,183 | 37,031 | 32,936 |
| Creditors | ||||||||||||
| Accruals and Deferred Income | -824,152 | -620,358 | 99,542 | 554,166 | -34,480 | 1,988,074 | -71,600 | 93,610 | 85,637 | -788,742 | 823,731 | 2,105 |
| Deferred Taxes & Provisions | ||||||||||||
| Cash flow from operations | 242,828 | |||||||||||
| Investing Activities | ||||||||||||
| capital expenditure | -1,660 | |||||||||||
| Change in Investments | 4,348 | -172,909 | -587,108 | -277,792 | -775,795 | 548,245 | 541,000 | |||||
| cash flow from investments | -4,348 | 172,909 | 587,108 | 277,792 | 775,795 | -1,660 | -548,245 | |||||
| Financing Activities | ||||||||||||
| Bank loans | ||||||||||||
| Group/Directors Accounts | ||||||||||||
| Other Short Term Loans | ||||||||||||
| Long term loans | ||||||||||||
| Hire Purchase and Lease Commitments | ||||||||||||
| other long term liabilities | 230,678 | -256,638 | -845,916 | -198,737 | 11,108 | 1,532,328 | ||||||
| share issue | ||||||||||||
| interest | ||||||||||||
| cash flow from financing | 158,705 | -298,640 | -845,916 | -1,169,286 | -764,687 | 1,532,328 | ||||||
| cash and cash equivalents | ||||||||||||
| cash | 671,676 | 628,978 | -3,605,061 | -877,803 | -825,055 | 2,115,691 | 1,811,163 | 735,934 | 474,018 | -244,268 | 433,489 | 414,382 |
| overdraft | ||||||||||||
| change in cash | 671,676 | 628,978 | -3,605,061 | -877,803 | -825,055 | 2,115,691 | 1,811,163 | 735,934 | 474,018 | -244,268 | 433,489 | 414,382 |
duchenne uk Credit Report and Business Information
Duchenne Uk Competitor Analysis
Perform a competitor analysis for duchenne uk by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in W14 area or any other competitors across 12 key performance metrics.
duchenne uk Ownership
DUCHENNE UK group structure
Duchenne Uk has no subsidiary companies.
Ultimate parent company
DUCHENNE UK
08030768
duchenne uk directors
Duchenne Uk currently has 6 directors. The longest serving directors include Mr Nicholas Crossley (Apr 2012) and Mrs Cecilia Crossley (Aug 2012).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Nicholas Crossley | England | 50 years | Apr 2012 | - | Director |
| Mrs Cecilia Crossley | United Kingdom | 46 years | Aug 2012 | - | Director |
| Mr Christopher Harris | England | 66 years | Jan 2019 | - | Director |
| Mr Sri Guru-Murthy | England | 54 years | Jun 2019 | - | Director |
| Mr Peter Williams | United Kingdom | 50 years | Mar 2022 | - | Director |
| Mrs Harriet Moynihan | England | 49 years | Mar 2023 | - | Director |
P&L
December 2023turnover
3.9m
+5%
operating profit
1.1m
0%
gross margin
52%
+2.55%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
4.4m
+0.25%
total assets
6.2m
+0.05%
cash
2.6m
+0.36%
net assets
Total assets minus all liabilities
duchenne uk company details
company number
08030768
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
85590 - Other education n.e.c.
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
72110 - Research and experimental development on biotechnology
incorporation date
April 2012
age
13
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
December 2023
previous names
the duchenne children's trust (April 2016)
accountant
-
auditor
CHARIOT HOUSE LTD
address
unit g.24, shepherd's building, charecroft way, london, W14 0EE
Bank
SANTANDER CORPORATE, SANTANDER CORPORATE
Legal Advisor
-
duchenne uk Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to duchenne uk.
duchenne uk Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DUCHENNE UK. This can take several minutes, an email will notify you when this has completed.
duchenne uk Companies House Filings - See Documents
| date | description | view/download |
|---|
